J Klarnet

1.1k citations

16 papers · 884 indexed · h-index 13

Impact in

Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology

Papers in

Immunology 12
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 6
Oncology 12
- CAR-T cell therapy research 10

Co-authors: Philip D. Greenberg D E Kern Martin A. Cheever Jack W. Singer K Lilleby Thomas R. Chauncey David Peace Michael C. Jensen
Journals: The Journal of Immunology (5 papers)The Journal of Experimental Medicine (2 papers)Journal of Clinical Oncology (1 paper)British Journal of Haematology (1 paper)Bone Marrow Transplantation (1 paper)
Partner nations: United States South Africa Canada

In The Last Decade

J Klarnet

16 papers receiving 852 citations

Peers

Countries citing papers authored by J Klarnet

Since Specialization

Citations

This map shows the geographic impact of J Klarnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Klarnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Klarnet more than expected).

Fields of papers citing papers by J Klarnet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Klarnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Klarnet. The network helps show where J Klarnet may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J Klarnet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J Klarnet Line = papers co-authored together J Klarnet links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Therapy of Disseminated Tumors by Adoptive Transfer of Specifically Immune T Cells1 Progress in tumor research ·Philip D. Greenberg, J Klarnet, D E Kern, Martin A. Cheever	2015	2
2	High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer Bone Marrow Transplantation ·Melis Evcimik, Taner Demirer, Scott D. Rowley, CD Buckner, Gary Goodman, Richard T. Maziarz, J Klarnet, Yazmine P. Huizar, Arya Dibyo Adisaputra, R. V. McCloskey, Robert H. Gersh, Rimma Goldberg, W. Garrett Nichols, Alice K. Jacobs, P L Weiden, Paul G. Montgomery, Saul E. Rivkin, FR Appelbaum, Jack W. Singer	1998	25
3	High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease. PubMed ·K Schiffman, CD Buckner, Richard T. Maziarz, David G. Maloney, Frederick R. Appelbaum, Oliver W. Press, Ted Gooley, Leona Holmberg, K Lilleby, R Clift, Yazmine P. Huizar, J Klarnet, C H Weaver, T Chauncey, Jack W. Singer	1997	22
4	High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma. Journal of Clinical Oncology ·Jack W. Singer, Scott D. Rowley, Taner Demirer, K Lilleby, K Schiffman, R A Clift, F R Appelbaum, A Fefer, 高橋綾, Rainer Storb, Thomas R. Chauncey, Richard T. Maziarz, J Klarnet, Peter A. McSweeney, Leona Holmberg, David G. Maloney, C H Weaver, CD Buckner	1996	83
5	Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG‐CSF): an analysis of factors correlating with the tempo of engraftment after transplantation British Journal of Haematology ·Jack W. Singer, K Longin, F R Appelbaum, S Rowley, Charles H. Weaver, K Lilleby, Ted Gooley, M. Lynch, Andreas Pawlas, J Klarnet, Thomas R. Chauncey, R Storb, C. Dean Buckner	1994	254
6	The Role of B Cells for in Vivo T Cell Responses to a Friend Virus-Induced Leukemia Science ·Kirk R. Schultz, J Klarnet, Randall S. Gieni, Kent T. HayGlass, Philip D. Greenberg	1990	77
7	Monoclonal antibody therapy of murine lymphoma: enhanced efficacy by concurrent administration of interleukin 2 or lymphokine-activated killer cells. PubMed ·Kirk R. Schultz, J Klarnet, David Peace, Martin A. Cheever, C Badger, Irwin D. Bernstein, P D Greenberg	1990	19
8	FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens. The Journal of Experimental Medicine ·J Klarnet, D E Kern, Kiyotaka Okuno, Curtis A. Holt, F Lilly, Philip D. Greenberg	1989	61
9	Helper-independent CD8+ cytotoxic T lymphocytes express IL-1 receptors and require IL-1 for secretion of IL-2. The Journal of Immunology ·J Klarnet, D E Kern, Steven Dower, L A Matis, Martin A. Cheever, Philip D. Greenberg	1989	29
10	Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumor. The Journal of Immunology ·D E Kern, David Peace, J Klarnet, Martin A. Cheever, Philip D. Greenberg	1988	12
11	Requirements for T cell recognition and elimination of retrovirally-transformed cells. PubMed ·PE Greenberg, J Klarnet, David H. Kern, Kiyotaka Okuno, S I Kuzmin, Martin A. Cheever	1988	7
12	Antigen-specific cultured T cells can mediate tumor therapy and provide long-term immunologic memory in vivo. PubMed ·Martin A. Cheever, J Klarnet, David Peace, Philip D. Greenberg	1987	1
13	Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory. The Journal of Immunology ·J Klarnet, L A Matis, D E Kern, Nathaniel I. Jurado, David Peace, Julie Thompson, Philip D. Greenberg, Martin A. Cheever	1987	38
14	Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells. The Journal of Experimental Medicine ·Martin A. Cheever, Mengwen Chen, J Klarnet, Philip D. Greenberg	1986	82
15	Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL. The Journal of Immunology ·D E Kern, J Klarnet, Michael C. Jensen, Philip D. Greenberg	1986	88
16	Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2. The Journal of Immunology ·John A. Thompson, David Peace, J Klarnet, D E Kern, P D Greenberg, Martin A. Cheever	1986	84

About J Klarnet

J Klarnet is a scholar working on Immunology, Oncology, Hematology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 16 papers that have together received 884 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (6 papers), Virus-based gene therapy research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Testicular diseases and treatments (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Hematology (361 citations), Immunology (491 citations), Oncology (434 citations), Genetics (58 citations) and Virology (21 citations). J Klarnet has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Philip D. Greenberg, D E Kern, Martin A. Cheever, Jack W. Singer, K Lilleby, Thomas R. Chauncey, David Peace, Michael C. Jensen, Ted Gooley and Charles H. Weaver. Their work appears in journals such as The Journal of Immunology, The Journal of Experimental Medicine, Journal of Clinical Oncology, British Journal of Haematology and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact